This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Acorda Therapeutics Inc (ACOR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 48.04M 41.88M 57.95M 34.64M
Receivables 30.78M 26.33M 22.83M 22.27M
Inventories 26.17M 20.96M 28.38M 38.42M
Other Current Assets 8.46M 16.48M 6.99M 3.73M
Total Current Assets 367.33M 333.06M 360.94M 311.17M
Property, Plant & Equipment, Gross 25.08M 25.84M 13.49M 11.31M
Accumulated Depreciation & Depletion 8.56M 9.13M 9.63M 8.11M
Property, Plant & Equipment, Net 16.52M 16.71M 3.86M 3.20M
Intangibles 17.46M 9.32M 8.77M 21.34M
Other Non-Current Assets 97.82M 104.61M 5.92M 6.39M
Total Non-Current Assets 239.79M 232.27M 18.55M 30.93M
Liabilities & Shareholder Equity
Total Assets 607.13M 565.33M 379.49M 342.10M
Accounts Payable 15.92M 30.54M 29.99M 16.96M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 96.64M 98.87M 87.34M 94.25M
Long Term Debt 3.23M 4.57M 6.26M 6.58M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 66.90M 75.97M 80.68M 90.01M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 70.13M 80.54M 86.94M 96.59M
Total Liabilities 166.77M 179.41M 174.28M 190.84M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 440.35M 385.92M 205.21M 151.26M
Common Par 41.00K 40.00K 39.00K 38.78K
Additional Paid In Capital 678.69M 640.67M 614.91M 591.65M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -238.08M -254.52M -409.48M -440.09M
Treasury Stock -329.00K -329.00K -329.00K -328.76K
Other Equity Adjustments 37.00K 62.00K 66.00K -12.58K
Total Capitalization 443.58M 390.49M 211.47M 157.84M
Total Equity 440.35M 385.92M 205.21M 151.26M
Total Liabilities & Stock Equity 607.13M 565.33M 379.49M 342.10M
Total Common Shares Outstanding 40.88M 39.79M 39.33M 38.77M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 12.42K 12.42K 12.42K 12.42K
Basic Weighted Shares Outstanding 40.21M 39.46M 39.00M 38.36M
Diluted Weighted Shares Outstanding 41.68M 40.33M 40.06M 38.36M
Number of Employees 421 378 328 305
Number of Part-Time Employees 0 0 0 0
ACOR News

ACOR Acorda Therapeutics Inc

Analysts Ratings for ACOR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 4 3 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ACOR ANALYST REPORT

Brokerage Partners

ACOR Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs